NASDAQ$PAYS
Paysign Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Reported a solid first quarter with revenue growth and continued expansion in key verticals.
Paysign reported a 23% increase in revenue compared to the previous year, driven by expansion in the plasma and patient affordability verticals. The company's investments in the patient affordability business are expected to yield positive returns. The first quarter has historically been the weakest due to slower plasma donations during tax season.
- Revenue increased by 23% compared to the last year.
- Gross spend volume was up 31.2% versus the year-ago period
- Unrestricted cash decreased $3.3 million to $6.4 million from December 31, 2022
- Company repurchased 200,000 shares of its common stock for $0.7 million.
Headline financials
Revenue & EPS history
Paysign · Revenue · Quarterly
$10.1M
Forward guidance
For the second quarter of 2023, Paysign expects total revenue to increase 15% to 20% and Adjusted EBITDA to increase 5% to 10% from the second quarter of 2022.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2023
+16.2%
Avg return
Earnings day
+4.1%
Avg return
5 days after
+7.8%
Avg return
30 days after
44%
27 / 61 earnings
Positive
+900.0%
Q3 2011
Best reaction
-29.6%
Q4 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +37.3% | -4.3% | — | |
| Q1 2026 | -12.6% | -12.0% | +4.8% | |
| Q3 2025 | +0.2% | -8.8% | +0.4% | |
| Q2 2025 | +13.0% | +4.2% | +0.6% | |
| Q1 2025 | +3.0% | +22.9% | +81.9% | |
| Q4 2024 | -8.5% | -14.5% | -8.1% | |
| Q3 2024 | +10.9% | +8.7% | -7.9% | |
| Q2 2024 | -6.7% | -14.4% | -9.2% | |
| Q1 2024 | -0.4% | +5.4% | -7.6% | |
| Q4 2023 | +20.5% | +10.2% | +31.9% | |
| Q3 2023 | +18.1% | +21.6% | +18.1% | |
| Q2 2023 | +6.4% | +8.6% | +16.0% | |
| Q1 2023 | -1.8% | -4.5% | -20.7% | |
| Q4 2022 | +4.2% | +7.6% | +0.3% | |
| Q3 2022 | -10.4% | +8.9% | +16.5% | |
| Q2 2022 | +7.4% | +15.3% | +33.5% | |
| Q1 2022 | -26.2% | -20.2% | -2.4% | |
| Q4 2021 | -6.6% | -16.6% | -21.4% | |
| Q3 2021 | -9.0% | -14.6% | -32.8% | |
| Q2 2021 | -2.4% | +5.6% | +16.7% | |
| Q1 2021 | -11.4% | -10.8% | +0.0% | |
| Q4 2020 | +11.7% | +5.1% | +0.8% | |
| Q3 2020 | -26.8% | -20.6% | -7.7% | |
| Q2 2020 | -18.9% | -30.5% | -45.3% | |
| Q1 2020 | -5.5% | -13.0% | -0.4% | |
| Q4 2019 | +27.3% | +82.9% | +102.7% | |
| Q3 2019 | +13.2% | +17.1% | +3.9% | |
| Q2 2019 | +2.5% | +6.3% | +2.7% | |
| Q1 2019 | -11.7% | -6.7% | +18.2% | |
| Q4 2018 | -1.7% | -7.5% | -1.0% | |
| Q3 2018 | -0.5% | -1.6% | -6.3% | |
| Q2 2018 | +10.1% | +2.7% | -2.7% | |
| Q1 2018 | -0.9% | +18.8% | +23.1% | |
| Q4 2017 | +19.0% | +20.6% | +44.3% | |
| Q3 2017 | +7.9% | +19.3% | +15.8% | |
| Q2 2017 | +2.8% | +9.4% | +0.0% | |
| Q1 2017 | -8.7% | -6.5% | -6.5% | |
| Q4 2016 | +4.7% | +0.0% | +0.0% | |
| Q3 2016 | +34.9% | +73.7% | +73.7% | |
| Q2 2016 | +0.0% | -5.0% | -20.0% | |
| Q1 2016 | -23.2% | — | — | |
| Q4 2015 | -29.6% | — | — | |
| Q3 2015 | -12.0% | — | — | |
| Q2 2015 | +6.3% | — | — | |
| Q1 2015 | +4.3% | — | — | |
| Q4 2014 | +71.2% | — | — | |
| Q2 2014 | -16.7% | — | — | |
| Q1 2014 | +0.0% | — | — | |
| Q4 2013 | +23.4% | — | — | |
| Q3 2013 | -17.9% | — | — | |
| Q2 2013 | -16.6% | — | — | |
| Q4 2012 | -4.3% | — | — | |
| Q1 2013 | -4.3% | — | — | |
| Q3 2012 | +18.5% | — | — | |
| Q2 2012 | +0.0% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2011 | +900.0% | — | — | |
| Q2 2011 | +0.0% | — | — | |
| Q1 2011 | +0.0% | — | — | |
| Q4 2010 | +5.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro